Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
111M
-
Number of holders
-
230
-
Total 13F shares, excl. options
-
66.7M
-
Shares change
-
+1.01M
-
Total reported value, excl. options
-
$4.99B
-
Value change
-
+$91.8M
-
Put/Call ratio
-
0.55
-
Number of buys
-
130
-
Number of sells
-
-101
-
Price
-
$74.78
Significant Holders of NovoCure Ltd - Common Stock (NVCR) as of Q3 2019
279 filings reported holding NVCR - NovoCure Ltd - Common Stock as of Q3 2019.
NovoCure Ltd - Common Stock (NVCR) has 230 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 66.7M shares
of 111M outstanding shares and own 60% of the company stock.
Largest 10 shareholders include FMR LLC (11.9M shares), BAILLIE GIFFORD & CO (8.65M shares), VANGUARD GROUP INC (6.94M shares), BlackRock Inc. (5.92M shares), Capital World Investors (5.03M shares), RENAISSANCE TECHNOLOGIES LLC (2.38M shares), STATE STREET CORP (1.62M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.59M shares), WELLS FARGO & COMPANY/MN (1.18M shares), and NORTHERN TRUST CORP (1.02M shares).
This table shows the top 230 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.